30.05.2016 • News • automotive • Elaine Burridge • Mitsui

Mitsui Raises Global PP Compounds Capacity

Mitsui Chemicals is expanding capacity for PP compounds in Europe, North America and India in response to growing demand in automotive applications.The company said it expects demand to continue increasing for lighter components and parts that do not require painting, such as bumpers and instrument panels.

Global capacity will rise from 1 million t/y to 1.05 million t/y by July 2017. In the US, two lines will be added at Advanced Composites, Mitsui’s affiliate in Sidney, Ohio, and another line will be added in Mexico, taking capacity in North America to 440,000 t/y from 410,000 t/y.

A 5,000 t/y line will be added in Germany, and 15,000 t/y extra capacity will be installed at Mitsui Prime Advanced Composites in Neemrana, India.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Top-Feature

most read

Photo
21.03.2025 • News

What’s Next for Pharma Supply Chains?

Sudden shifts in demand, supply shortages and global collapse have put immense pressure on pharmaceutical logistics. To address these challenges, PHARMAP 2025 brings together industry experts to discover AI-driven supply chain optimisation, strategic logistics partnerships and digital solutions that enhance efficiency and resilience in the pharmaceutical supply chain.